Cooper S J
Neuropharmacology. 1982 May;21(5):483-6. doi: 10.1016/0028-3908(82)90036-3.
Midazolam, a new water-soluble benzodiazepine, increased the water intake of water deprived rats. The effect was abolished by concurrent treatment with the benzodiazepine antagonist, RO15-1788. The lack of effect of RO15-1788 on phenobarbitone-induced hyperdipsia confirmed the specificity of the antagonist action. Alone RO15-1788 (0.3-30 mg . kg-1) had no effect on thirst-induced drinking. Thus, it was not necessary to posit the action of an endogenous benzodiazepine ligand in thirst-induced drinking.
咪达唑仑是一种新型水溶性苯二氮䓬类药物,可增加禁水大鼠的饮水量。苯二氮䓬类拮抗剂RO15 - 1788同时给药可消除该作用。RO15 - 1788对苯巴比妥诱导的烦渴症无效,证实了拮抗剂作用的特异性。单独使用RO15 - 1788(0.3 - 30毫克·千克⁻¹)对渴感诱导的饮水无影响。因此,没有必要假定内源性苯二氮䓬配体在渴感诱导的饮水中起作用。